Latest Avandia Stories
RECORD trial also demonstrates durable blood sugar control over time with Avandia LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 5 /PRNewswire/ -- Clinical trial results presented today at the American Diabetes Association annual meeting show that overall rates of cardiovascular hospitalization and cardiovascular death are similar in patients taking Avandia (rosiglitazone) compared to those receiving metformin and sulfonylurea. Results from the 4,447-patient Rosiglitazone...
Today's announcement hurts thousands of Avandia patients, counsel says HOUSTON, June 5 /PRNewswire/ -- Noted Houston trial lawyer Mark Lanier of The Lanier Law Firm says "useless trick science" is the basis for a new study being unveiled today in New Orleans by drug maker GlaxoSmithKline (NYSE: GSK) about the side effects caused by the company's diabetes medication Avandia, which reportedly has been linked to heart problems in thousands of patients. Mr.
- Welchol Added to Metformin Significantly Reduced A1C and LDL-C in Patients with Type 2 Diabetes - Open-Label Extension Study Demonstrated the Safety and Durability of Welchol for up to 78 Weeks of Treatment PARSIPPANY, N.J., May 15 /PRNewswire/ -- Daiichi Sankyo, Inc.
A study released on Wednesday shows that long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes.
New findings support the claim that a controversial diabetes pill failed to significantly slow plaque buildup in heart arteries compared with an older drug.
Public Citizen, a consumer advocate group, has called on the US to ban sales and distribution of the diabetes drug Avandia due to certain risks found to be linked with the drug.
PHILADELPHIA, Oct. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline today issued the following response to a petition filed by Public Citizen to the U.S.
Treatment for diabetic Americans has doubled in cost during the past six years. Last year, the bill hit an eye-popping $12.5 billion.
A wrongful death suit was filed against GlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in California Superior Court, charging that Avandia, prescribed for Type 2 Diabetes, led to heart attacks, congestive heart failure and other fatal cardiovascular injuries in seven individuals.
PHILADELPHIA, July 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline announces today that the U.S.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.